Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

SRx Health Solutions (SRXH) Enterprise Value (2025 - 2026)

SRx Health Solutions' Enterprise Value history spans 13 years, with the latest figure at -$1.3 million for Q3 2025.

  • For Q3 2025, Enterprise Value fell 1134.91% year-over-year to -$1.3 million; the TTM value through Sep 2025 reached -$1.3 million, down 1134.91%, while the annual FY2025 figure was -$1.3 million, N/A changed from the prior year.
  • Enterprise Value reached -$1.3 million in Q3 2025 per SRXH's latest filing, down from -$912000.0 in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$106000.0 in Q3 2024 to a low of -$33.3 million in Q3 2021.
  • Average Enterprise Value over 5 years is -$9.1 million, with a median of -$3.9 million recorded in 2024.
  • Peak YoY movement for Enterprise Value: plummeted 1498.32% in 2021, then skyrocketed 97.21% in 2024.
  • A 5-year view of Enterprise Value shows it stood at -$28.9 million in 2021, then surged by 45.5% to -$15.8 million in 2022, then skyrocketed by 71.76% to -$4.5 million in 2023, then soared by 31.18% to -$3.1 million in 2024, then skyrocketed by 57.31% to -$1.3 million in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Enterprise Value are -$1.3 million (Q3 2025), -$912000.0 (Q2 2025), and -$1.1 million (Q1 2025).